From 2013 to 2018, there was considerable fluctuation in the import of composite diagnostic or laboratory reagents to the Netherlands. The volume dipped sharply between 2013 and 2016 but saw recovery from 2017, with marked growth in 2018. From 2019 onward, there was a period of relative stability with modest positive year-on-year growth, maintaining a consistent pattern through 2023. The value stood at 16.185 million kilograms in 2023. The year-on-year growth for 2022 and 2023 was approximately 1.58% and 1.53%, respectively. Over the last five years, the CAGR was marginally negative at -0.02%. Moving forward, from 2024 to 2028, the forecasted CAGR is projected to be 1.08%, indicating a steady yet modest growth trajectory in the import volume, culminating in a 5.53% growth rate over the period.
Future Trends to Watch For:
- **Technological advancements in diagnostics**: Continued innovation may drive an increase in demand for these reagents.- **Global supply chain stability**: Any disruptions can markedly affect import volumes.- **Regulatory changes**: New regulations in the EU could impact import patterns.- **Economic conditions**: Economic growth or downturns in the Netherlands will influence healthcare spending and related imports.